Study to Evaluate the Prospective Payment System

CompletedOBSERVATIONAL
Enrollment

2,248

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Chronic Kidney Disease
Trial Locations (41)

10016

Research Site, New York

10461

Research Site, The Bronx

11235

Research Site, Brooklyn

11378

Research Site, Maspeth

22030

Research Site, Fairfax

25015

Research Site, South Charleston

27021

Research Site, King

27055

Research Site, Yadkinville

27103

Research Site, Winston-Salem

30344

Research Site, East Point

30512

Research Site, Blairsville

33028

Research Site, Pembroke Pines

36542

Research Site, Gulf Shores

39347

Research Site, Pachuta

39429

Research Site, Columbia

62301

Research Site, Quincy

68510

Research Site, Lincoln

68512

Research Site, Lincoln

68521

Research Site, Lincoln

72761

Research Site, Siloam Springs

72764

Research Site, Springdale

76015

Research Site, Arlington

77004

Research Site, Houston

77021

Research Site, Houston

77074

Research Site, Houston

90095

Research Site, Los Angeles

90301

Research Site, Inglewood

90606

Research Site, Whittier

91205

Research Site, Glendale

91324

Research Site, Northridge

91702

Research Site, Azusa

91723

Research Site, Covina

91745

Research Site, Hacienda Heights

91773

Research Site, San Dimas

91790

Research Site, West Covina

93309

Research Site, Bakersfield

93534

Research Site, Lancaster

96816

Research Site, Honolulu

96817

Research Site, Honolulu

07039

Research Site, Livingston

00936

Research Site, San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT01717989 - Study to Evaluate the Prospective Payment System | Biotech Hunter | Biotech Hunter